Yubo International Biotech Ltd
YBGJ· OTC
YBGJYubo International Biotech Ltd
Source filing unavailable
| Metric | Q4 2020 | Q4 2019 | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$438.68K | -$140.95K | -$33.00K | -$15.00K |
| EPS Diluted | $0.00 | $0.00 | — | — |
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
